122 related articles for article (PubMed ID: 27232229)
1. The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated Disorders.
Lisman T; de Moerloose P
Semin Thromb Hemost; 2016 Jun; 42(4):331-2. PubMed ID: 27232229
[No Abstract] [Full Text] [Related]
2. [Modern data on the chemistry and physiology of fibrinogen].
Andreenko GV
Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801
[No Abstract] [Full Text] [Related]
3. Fibrinogen Aarhus and factor XIII induced polymerization and gel formation.
Hessel B; Adamson L; Procyk R; Therkildsen L; Stenbjerg S; Blombäck B
Br J Haematol; 1987 Jul; 66(3):355-61. PubMed ID: 3620354
[TBL] [Abstract][Full Text] [Related]
4. Haemorrhagic disease due to hereditary deficiency of factor XIII. Description of a family.
Broccia G
Acta Haematol; 1970; 44(3):177-85. PubMed ID: 4991915
[No Abstract] [Full Text] [Related]
5. The therapy of factor 13 deficiency.
Duckert F
Bibl Haematol; 1965; 23():1354-7. PubMed ID: 5885230
[No Abstract] [Full Text] [Related]
6. Mechanism of the action of factor XIII on the structure of fibrin in the normal and pathological states.
Kleimenov AN; Rozenfel'd MA; Piruzyan LA; Titova MI; Shimkevich LL
Biol Bull Acad Sci USSR; 1978; 5(5):610-4. PubMed ID: 754811
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen and FDP-models of molecular pathology?
Gaffney PJ
Br J Haematol; 1973 Aug; 25(2):271-2. PubMed ID: 4269481
[No Abstract] [Full Text] [Related]
8. Human fibrinogen.
Shafer JA; Higgins DL
Crit Rev Clin Lab Sci; 1988; 26(1):1-41. PubMed ID: 3286116
[TBL] [Abstract][Full Text] [Related]
9. [Nonenzymatic fibrinolysis].
Dzhurdzhev A; Atanasov K
Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
[No Abstract] [Full Text] [Related]
10. [Static and functional biochemistry of fibrinogen. Possible practical usefulness (author's transl)].
Aznar J; Regañon E; Vila V
Sangre (Barc); 1978; 23(5B):620-30. PubMed ID: 725709
[No Abstract] [Full Text] [Related]
11. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
[TBL] [Abstract][Full Text] [Related]
13. [Hemostasis disorders in liver cirrhosis].
Judkiewicz L; Olszañska T; Tomaszewska L
Pol Tyg Lek; 1973 May; 28(19):708-11. PubMed ID: 4270099
[No Abstract] [Full Text] [Related]
14. The half-life of factor XIII in vivo.
Miloszewski K; Losowsky MS
Br J Haematol; 1970 Dec; 19(6):685-90. PubMed ID: 5492488
[No Abstract] [Full Text] [Related]
15. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
[TBL] [Abstract][Full Text] [Related]
16. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery.
Blome M; Isgro F; Kiessling AH; Skuras J; Haubelt H; Hellstern P; Saggau W
Thromb Haemost; 2005 Jun; 93(6):1101-7. PubMed ID: 15968395
[TBL] [Abstract][Full Text] [Related]
17. Cross-linking of fibrinogen by factor XIII zymogen is not apparent in vivo.
Shainoff JR; DiBello PM
Thromb Haemost; 2003 May; 89(5):943-4; author reply 944-5. PubMed ID: 12719793
[No Abstract] [Full Text] [Related]
18. THE MODE OF ACTION OF THE LAKI-LORAND FACTOR IN THE CLOTTING OF FIBRINOGEN.
Chandrasekhar N; Osbahr A; Laki K
Biochem Biophys Res Commun; 1964 Mar; 15(2):182-7. PubMed ID: 26410914
[No Abstract] [Full Text] [Related]
19. Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature.
Britten AF
Am J Med; 1967 Nov; 43(5):751-61. PubMed ID: 6054840
[No Abstract] [Full Text] [Related]
20. A longitudinal study of factor XIII activity, fibrinogen concentration, platelet count and clot strength during normal pregnancy.
Karlsson O; Jeppsson A; Hellgren M
Thromb Res; 2014 Sep; 134(3):750-2. PubMed ID: 25053372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
